BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $315,521,551 | -19.9% | 8,360,392 | -3.3% | 0.40% | -12.0% |
| Q2 2023 | $393,749,796 | +5.1% | 8,642,454 | -6.5% | 0.45% | +1.1% |
| Q1 2023 | $374,733,127 | -5.6% | 9,238,991 | +18.6% | 0.44% | -5.1% |
| Q4 2022 | $397,006,253 | +9.7% | 7,789,008 | +15.9% | 0.47% | +5.6% |
| Q3 2022 | $361,864,000 | -14.0% | 6,718,582 | +2.5% | 0.44% | -6.1% |
| Q2 2022 | $420,867,000 | -15.1% | 6,552,487 | +2.5% | 0.47% | +25.5% |
| Q1 2022 | $495,904,000 | -13.5% | 6,395,463 | -4.2% | 0.38% | -21.0% |
| Q4 2021 | $572,999,000 | +252.0% | 6,675,192 | +229.8% | 0.48% | +243.2% |
| Q3 2021 | $162,803,000 | +6760.6% | 2,024,158 | +6767.6% | 0.14% | +6850.0% |
| Q2 2021 | $2,373,000 | +29.9% | 29,474 | +36.1% | 0.00% | -33.3% |
| Q1 2021 | $1,827,000 | -77.0% | 21,658 | -78.1% | 0.00% | -75.0% |
| Q4 2020 | $7,948,000 | -4.9% | 99,044 | +0.3% | 0.01% | -14.3% |
| Q3 2020 | $8,357,000 | -52.4% | 98,730 | -51.5% | 0.01% | -53.3% |
| Q2 2020 | $17,539,000 | -1.1% | 203,695 | -6.7% | 0.03% | -16.7% |
| Q1 2020 | $17,735,000 | -12.0% | 218,430 | -9.3% | 0.04% | +24.1% |
| Q4 2019 | $20,145,000 | +1275.1% | 240,918 | +1338.4% | 0.03% | +1350.0% |
| Q3 2019 | $1,465,000 | -64.4% | 16,749 | -66.7% | 0.00% | 0.0% |
| Q2 2019 | $4,116,000 | +248.5% | 50,247 | +245.8% | 0.00% | 0.0% |
| Q1 2019 | $1,181,000 | +80.9% | 14,529 | +46.5% | 0.00% | +100.0% |
| Q4 2018 | $653,000 | -14.5% | 9,920 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $764,000 | -13.8% | 9,920 | -17.3% | 0.00% | -50.0% |
| Q2 2018 | $886,000 | +6.4% | 12,000 | -6.2% | 0.00% | 0.0% |
| Q1 2018 | $833,000 | -21.0% | 12,800 | -11.7% | 0.00% | 0.0% |
| Q4 2017 | $1,055,000 | -25.7% | 14,500 | -35.8% | 0.00% | -33.3% |
| Q3 2017 | $1,419,000 | -63.3% | 22,600 | -64.6% | 0.00% | -57.1% |
| Q2 2017 | $3,870,000 | +14.3% | 63,900 | -2.1% | 0.01% | +16.7% |
| Q1 2017 | $3,386,000 | +144.8% | 65,300 | +109.3% | 0.01% | +100.0% |
| Q4 2016 | $1,383,000 | -71.6% | 31,200 | -69.5% | 0.00% | -66.7% |
| Q3 2016 | $4,873,000 | -46.4% | 102,366 | -49.1% | 0.01% | 0.0% |
| Q2 2016 | $9,086,000 | +111.3% | 200,932 | +91.9% | 0.01% | 0.0% |
| Q1 2016 | $4,301,000 | -49.2% | 104,700 | -52.8% | 0.01% | -47.1% |
| Q4 2015 | $8,463,000 | -97.2% | 221,829 | -97.6% | 0.02% | -97.4% |
| Q3 2015 | $307,665,000 | -53.1% | 9,366,207 | -0.2% | 0.66% | -49.2% |
| Q2 2015 | $656,307,000 | +13.7% | 9,385,209 | +11.3% | 1.30% | +14.7% |
| Q1 2015 | $577,464,000 | +9.7% | 8,430,129 | +17.4% | 1.13% | +4.3% |
| Q4 2014 | $526,248,000 | +11.9% | 7,180,347 | +9.6% | 1.09% | +7.6% |
| Q3 2014 | $470,151,000 | +6.5% | 6,550,804 | +7.3% | 1.01% | +2.4% |
| Q2 2014 | $441,569,000 | -2.3% | 6,107,454 | -0.5% | 0.98% | +26.3% |
| Q1 2014 | $451,748,000 | +12.2% | 6,139,566 | +6.0% | 0.78% | +8.0% |
| Q4 2013 | $402,702,000 | +22.0% | 5,790,110 | +15.3% | 0.72% | +11.9% |
| Q3 2013 | $329,982,000 | +4.8% | 5,023,314 | +10.6% | 0.64% | -6.1% |
| Q2 2013 | $314,722,000 | – | 4,543,423 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |